<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='682-930'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>FIP1L1-PDGFR Gene Rearrangement Test </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">FIP1L1-PDGFR Gene Rearrangement Test </h1>
<div class="post-text">
<p>The FIP1L1-PDGFR Gene Rearrangement Test is a specialized genetic test that helps in diagnosing and
managing a group of rare blood disorders known as hypereosinophilic syndromes (HES). HES
encompasses conditions characterized by an abnormally high number of eosinophils, a type of white
blood cell, in the blood or tissues. The FIP1L1-PDGFR gene rearrangement is a specific chromosomal
abnormality found in a subset of patients with HES. This abnormality involves the fusion of the FIP1L1
gene and the PDGFR-alpha gene, resulting in a mutated gene that leads to uncontrolled cell growth. </p>

<p>HES can cause a range of symptoms and complications as eosinophils can affect various organs,
including the heart, lungs, and skin. The detection of the FIP1L1-PDGFR gene rearrangement has
significant implications for the management and treatment of HES, as patients with this mutation
respond well to specific targeted therapies, such as imatinib. </p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">FIP1L1-PDGFR Gene Rearrangement Test </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Blood or Bone Marrow </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>No special preparation is needed for this test. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>10 days </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>â‚¹ 7500 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
<h2 class="test-h2 mt-3">What is the FIP1L1-PDGFR Gene Rearrangement Test?</h2>
<p>The FIP1L1-PDGFR Gene Rearrangement Test is a laboratory test used to detect the presence of a
specific genetic mutation where parts of the FIP1L1 and PDGFR-alpha genes are fused. This mutation is
associated with certain types of hypereosinophilic syndromes (HES).</p>

<h2 class="test-h2 mt-3">Why is the FIP1L1-PDGFR Gene Rearrangement Test important?</h2>
<p>This test is important because identifying the FIP1L1-PDGFR gene rearrangement can help in diagnosing
certain forms of HES. Additionally, it helps in determining the appropriate treatment, as patients with
this gene rearrangement respond well to targeted therapies like imatinib.</p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->


<h2 class="test-h2 mt-3">How is the sample collected for the FIP1L1-PDGFR Gene Rearrangement Test?</h2>
<p>The sample is usually collected from blood or bone marrow. A healthcare professional will draw blood
from a vein, usually in your arm. In some cases, a bone marrow sample might be taken from the hip
bone.</p>

<h2 class="test-h2 mt-3">What does a positive result mean?</h2>
<p>A positive result indicates the presence of the FIP1L1-PDGFR gene rearrangement, which is associated
with certain types of HES. This information is vital for determining the best treatment plan.</p>

<h2 class="test-h2 mt-3">Are there any risks associated with the test?</h2>
<p>The risks associated with blood draw are minimal, including slight pain, bruising, or infection at the
needle site. Bone marrow aspiration carries more risks, including infection and bleeding.</p>

<h2 class="test-h2 mt-3">What are the symptoms of hypereosinophilic syndromes (HES)?</h2>
<p>Symptoms of HES vary widely and can include fatigue, cough, skin rashes, chest pain, shortness of
breath, and swelling and inflammation of various organs.</p>

<h2 class="test-h2 mt-3">Are there modifiable factors that can influence the risk of developing HES?</h2>
<p>There are no known modifiable risk factors for HES as it is often related to genetic mutations.
Environmental factors contributing to HES are not well understood.</p>

<h2 class="test-h2 mt-3">Can HES be cured?</h2>
<p>There is no cure for HES, but treatments, especially targeted therapies for those with the FIP1L1-PDGFR
gene rearrangement, can effectively manage the symptoms and complications.</p>

<h2 class="test-h2 mt-3">What doctor should I consult if I have been diagnosed with HES?</h2>
<p>If you have been diagnosed with HES, you should consult a hematologist, who is specialized in blood
disorders.</p>

<h2 class="test-h2 mt-3">What are the treatment options for patients with the FIP1L1-PDGFR gene rearrangement?</h2>
<p>Patients with the FIP1L1-PDGFR gene rearrangement respond well to targeted therapy with drugs like
imatinib, which inhibit the action of the abnormal protein produced by the gene fusion.</p>

<h2 class="test-h2 mt-3">Is this test routinely recommended?</h2>
<p>This test is not routinely recommended for the general population. It is specifically used in individuals
suspected of having HES based on clinical symptoms and findings.</p>

<h2 class="test-h2 mt-3">What is the prognosis for individuals with the FIP1L1-PDGFR gene rearrangement?</h2>
<p>The prognosis for individuals with this gene rearrangement is generally good if they receive appropriate
treatment. Targeted therapy can control symptoms and prevent complications.</p>

<h2 class="test-h2 mt-3">How common is the FIP1L1-PDGFR gene rearrangement?</h2>
<p>The FIP1L1-PDGFR gene rearrangement is rare and is only found in a subset of patients with
hypereosinophilic syndromes.</p>

<h2 class="test-h2 mt-3">Are family members at risk?</h2>
<p>While HES can have a genetic component, the risk to family members is not well-established. However,
family members of an affected individual may be advised to undergo genetic counseling.</p>

<h2 class="test-h2 mt-3">Can the FIP1L1-PDGFR gene rearrangement be detected before symptoms appear?</h2>
<p>In theory, it is possible to detect the gene rearrangement before symptoms appear through genetic
testing, but it is usually diagnosed when evaluating the cause of symptoms suggestive of HES.</p>

<p>The FIP1L1-PDGFR Gene Rearrangement Test is an invaluable diagnostic tool in the management of
hypereosinophilic syndromes. The identification of this gene rearrangement guides treatment decisions
and can significantly impact the course of the disease. If you or a family member are experiencing
symptoms or have been diagnosed with HES, consulting your doctor about the potential benefits of this
test is crucial. Through informed medical care, individuals with HES can lead a productive life while
managing the condition effectively.</p>
</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>